The Worst-Performing Medtech IPOs Of 2014 (CareDx)

Location: Brisbane, CaliforniaProducts: Molecular diagnostics company focused on tests for heart transplant recipients

December 15, 2014

1 Min Read
The Worst-Performing Medtech IPOs Of 2014 (CareDx)

careDX.png

Location: Brisbane, California

Products: Molecular diagnostics company focused on tests for heart transplant recipients

Date of IPO: July 16

IPO Offer Price: $10 

Deal Size: $40 million

Returns: -30%

 arrow-for-slideshow-right.jpg   

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like